Efficacy and safety of sofosbuvir and daclatasvir for 8 weeks in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus Genotype 3 Infection

Saved in:
Bibliographic Details
Published inJournal of hepatology Vol. 66; no. 1; pp. S299 - S300
Main Authors Hezode, C, Leroy, V, Rosa, I, Roudot-Thoraval, F, Pawlotsky, J.-M, de Ledinghen, V, Bronowicki, J.-P
Format Journal Article
LanguageEnglish
Published 2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
ISSN:0168-8278
DOI:10.1016/S0168-8278(17)30916-9